Medicine moves
too slow

At Velsera, we’re changing that.

Built for Breakthroughs

Velsera is a global precision medicine technology company

that accelerates the discovery, development, and delivery

of precision medicine through integrated AI-enhanced software and services.

We are on a mission to make breakthroughs happen faster,

so that lives are improved sooner.

Who we serve

Velsera accelerates clinical & discovery breakthroughs.

 

Biotech &
Pharma

Accelerate your research breakgthroughs and novel drug launches.

Clinical Diagnostic Labs

Accelerate the scale up of your genetic testing & unlock the value in your data.

NGS Assay & Equipment Manufacturers

Bring new tests to market and scale up testing fast.

Non-Profits and Government Agencies

Accelerate your research breakthroughs and unlock the value in your data.

Revealing the path from discovery to clinical impact.

Velsera pushes medicine forward

As one of the largest omics analytics providers in the market

80+

Active clinical NGS lab customers

250,000+

NGS samples sequences

20+

Productized NGS assays available 'off the shelf'

+20% p.a.

Year over year sequencing volume

Advancing breakthrough discoveries to tackle the world's most pressing health challenges

7/10

Top pharmas supported by our technology-enabled products and services

18,000+

Researchers using the Seven Bridges Platform

1.7 Million

Patients

48 PB

Of multi-omic molecular data

Trusted widely across the industry

A selection of our customers

Powerful platforms

One singular vision

Technology designed to accelerate the momentum of medicine - from discovery to diagnostics.

 

 

Our Integrated Solutions ‘menu’.

 

Clinical & Multi-omic Data Access

Harmonize and augment your data to unlock the value within.

Analysis & Bioinformatics

Use cutting edge technology to make new discoveries and breakthroughs faster.

Companion Diagnostic Development & Scaling

Develop better diagnostics that scale faster, accelerating novel drug uptake.

NGS Assay Development & Expansion

Bring new tests to market and scale-up fast.

IVD Compliance Transition

Effectively navigate and grow in the changing regulatory environment.

Clinical Interpretation & Reporting

Accelerate the scale up of your genetic testing & unlock the value in your data.

Testimonials

Hear how leading life sciences companies and clinical diagnostic labs trust our technology to accelerate discovery and improve patient care.

The Clinical Genomics Workspace (CGW) by Velsera has provided our laboratory with a seamless, integrated software solution that allows us to spend more time analyzing the sequencing data and generating clinical reports and less time worrying about logistics.

James Patrick Solomon, M.D., Ph.D.

Medical Director, Clinical Genomics Laboratory / Weill Cornell Medicine

Using standard computational tools, we are already finding a large number of novel variants of African and Native American ancestries within the Brazilian genomes. We want to use the graph-based approach in order to capture the full value of our genomes.

Interpreting large-scale, complex transcriptomics data is critically important for understanding the molecular and cellular basis of disease. We are confident that by working with the unique multi-cloud technology developed by Velsera and by benefiting from the depth and breadth of their expertise in bioinformatics and cloud computing, these solutions will assist us in maximizing the value of the data we generate.

Pharma Leader

Vice President, Medicinal Sciences / Top 10 Global Biopharmaceutical Company

There's going to be a bottleneck in the professional component as well sometimes. Velsera allowed us to widen that bottleneck and to have more uniformity of reporting.

Eric Loo, MD

Asst. Professor, Pathology and Lab Medicine / Dartmouth-Hitchcock Health